The Role of the Virus Specific T-Cell Response in Acute and Chronic HBV and HCV Infection;Die Rolle der Virusspezifischen T-Zellantwort bei der Akuten und Chronischen Hepatitis-B- und -C-Virusinfektion

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 1, 2004, Pages 39-46

  Panther, E ^a   Spangenberg, H C ^a   Neumann Haefelin, C ^a   Rosler K ^a   Blum, H E ^a   Von Weizsacker F ^a   Thimme, R ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Hepatitis B; Hepatitis C; Immunology; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE;

CELLULAR IMMUNITY; CHRONIC LIVER DISEASE; ERADICATION THERAPY; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PERSISTENT VIRUS INFECTION; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; MICE; MICE, TRANSGENIC; PAN TROGLODYTES; T-LYMPHOCYTES; TIME FACTORS; VIRAL LOAD;

EID: 0347087501     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812688     Document Type: Review

References (65)

1. Bertoni R, Sidney J, Fowler P et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997; 100: 503-513
2. Maini MK, Boni C, Ogg GS et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999; 117: 1386-1396
3. Thimme R, Chang KM, Pemberton J et al. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. J Virol 2001; 75: 3984-3987
4. Urbani S, Boni C, Missale G et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002; 76: 1242-1234
5. Thimme R, Wieland S, Steiger C et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76
6. Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol 2000; 156: 1117-1132
7. Guidotti LG, Ishikawa T, Hobbs MV et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36
8. Guidotti LG, Rochford R, Chung J et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825-829
9. Baron J, Gardiner L, Nishimura S et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002; 16: 583-594
10. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91
11. Kakimi K, Guidotti LG, Koezuka Y et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-930
12. Pasquetto V, Guidotti L, Kakimi K et al. C. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med 2000; 192: 529-536
13. Webster G, Reignat S, Maini M et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2001; 32: 1117-1124
14. Rehermann B, Ferrari C, Pasquinelli C et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104-1108
15. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472-1477
16. Boni C, Bertoletti A, Penna A et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102: 968-975
17. Boni C, Penna A, Ogg G et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963-971
18. Rehermann B, Chang KM, McHutchinson J et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70: 7092-7102
19. Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191: 1269-1280
20. Kakimi K, Lane TE, Wieland S et al. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 2001; 194: 1755-1766
21. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology 2001; 33: 321-327
22. Gerlach J, Diepolder H, Zachoval R et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125: 80-88
23. Diepolder HM, Zachoval R, Hoffmann RM et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-1007
24. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T- cell response in acute hepatitis C. Gastroenterology 1999; 117: 933-941
25. Gruner NH, Gerlach TJ, Jung MC et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000; 181: 1528-1536
26. Lechner F, Gruener NH, Urbani S et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000; 30: 2479-2487
27. Lechner F, Wong DK, Dunbar PR et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191: 1499-1512
28. Thimme R, Oldach D, Chang KM et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection. J Exp Med 2001; 194: 1395-1406
29. Cooper S, Erickson AL, Adams EJ et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10: 439-449
30. Thimme R, Bukh J, Spangenberg H et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 2002; 99: 15 661-15 668
31. Su A, Pezacki J, Wodicka L et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002; 99: 16 669-16 674
32. Frese M, Schwarzle V, Barth K et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002; 35: 694-703
33. Foy E, Li K, Wang C et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003; 300: 1445-1448
34. Gale MJ, Korth Mand Katze M. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 1998; 10: 157-162
35. Tan SL, Katze MG. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 2001; 284: 1-12
36. Taylor D, Shi S, Romano P et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999; 285: 107-110
37. Crotta S, Stilla A, Wack A et al. Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein. J Exp Med 2002; 195: 35-42
38. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein e2 to CD81 inhibits natural killer cell functions. J Exp Med 2002; 195: 43-50
39. Missale G, Bertoni R, Lamonaca V et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98: 706-714
40. Bain C, Fatmi A, Zoulim F et al. Impaired Allostimulatory Function of Dendritic Cells in Chronic Hepatitis C Infection. Gastroenterology 2001; 120: 512-524
41. Erickson AL, Kimura Y, Igarashi S et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001; 15: 885-895
42. Gruener NH, Lechner F,Jung MC et al. Sustained dysfunction of antiviral cd8(+) t lymphocytes after infection with hepatitis c virus. J Virol 2001; 75: 5550-5558
43. Battegay M, Fikes J, Di Bisceglie AM et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995; 69: 2462-2470
44. Cerny A, McHutchison JG, Pasquinelli C et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95: 521-530
45. Chang K, Thimme R, Melpolder J et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33: 267-276
46. Ferrari C, Valli A, Galati L et al. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-295
47. Koziel MJ, Dudley D, Afdhal N et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993; 67: 7522-7532
48. Koziel MJ, Dudley D, Afdhal N et al. HLA class 1-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995; 96: 2311-2321
49. Wong DK, Dudley DD, Dohrenwend PB et al. Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV. J Virol 2001; 75: 1229-1235
50. Grabowska AM, Lechner F, Klenerman P et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol 2001; 31: 2388-2394
51. He XS, Rehermann B, Lopez-Labrador FX et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999; 96: 5692-5697
52. Ulsenheimer A, Gerlach J, Gruener N et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. J Virol 2003; 37: 1189-1198
53. Wedemeyer H, He XS, Nascimbeni M et al. Impaired Effector Function of Hepatitis C Virus-Specific CD8(+) T Cells in Chronic Hepatitis C Virus Infection. J Immunol 2002; 169: 3447-3458
54. Appay V, Dunbar P, Callan M et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 84: 379-385
55. Farci P, Alter HJ, Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135-140
56. Kao JH, Chen PJ, Wang JT et al. Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis. J Med Virol 1996; 50: 303-308
57. Lai ME, Mazzoleni AP, Argiolu F et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343: 388-390
58. Prince AM, Brotman B, Huima T et al. Immunity in hepatitis C infection. J Infect Dis 1992; 165: 438-443
59. Proust B, Dubois F, Bacq Y et al. Two successive hepatitis C virus infections in an intravenous drug user. J Clin Microbiol 2000; 38: 3125-3127
60. Thimme R, Spangenberg H, Blum HE. Bridge over troubled water: Protection against hepatitis C virus persistence? Hepatology 2002; 36: 1537-1539
61. Mehta SH, Cox A, Hoover DR et al. Protection against persistence of hepatitis C. Lancet 2002; 359: 1478-1483
62. Bassett SE, Guerra B, Brasky K et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 2001; 33: 1479-1487
63. Major ME, Mihalik K, Puig M et al. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 2002; 76: 6586-6595
64. Weiner AJ, Paliard X, Selby MJ et al. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol 2001; 75: 7142-7148
65. Shoukry N, Grakoui A, Houghton M et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003; 197: 1645-1655